ClearanceBrief
Recall Z-2416-2015 ยท LDP Colorimetry, Acetaminophen

Siemens Healthcare Diagnostics, Inc.

ADVIA Chemistry Acetaminophen reagents; for in vitro diagnostic use in the quantitative determination of acetaminophen in human serum and plasma (lithium heparin) on ADVIA Chemistry systems.

DateAug 19, 2015 (initiated Jun 30, 2015)
StatusTerminated
ReasonA change in the concentration of N-acetylcysteine (NAC) that may cause interference for the ADVIA Chemistry Systems Acetaminophen assay for certain lots.
Root causeUnknown/Undetermined by firm
ActionSiemens sent an Urgent Medical Device Correction letter dated June 30, 2015, to all affected customers.The letter identified the product the problem and the action needed to be taken by the customer. Siemens Healthcare Diagnostics is conducting a voluntary recall for the ADVIA Chemistry Acetaminophen reagent, for all in date and future kit lots. Customers were informed of the revised interference levels of N-acetyl cysteine (NAC) of 200 mg/dL, for the ADVIA Chemistry Acetaminophen assay. Customers are requested to complete and return the Effectiveness Check questionnaire attached to the Urg
Quantity1032
DistributionWorldwide Distribution - US (nationwide) and to the countries of : Canada, Netherlands, Great Britain, Norway, Sweden, Spain, Italy, Germany, France, Finland, Belgium, Portugal, Czech Republic, Israel, Poland, Turkey and Bahrain.
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K100200ADVIA CHEMISTRY ACETAMINOPHEN REAGENT, MODEL REF 07989138
Siemens Healthcare Diagnostics, Aug 2, 2010